Ketan Mehta

Ketan Mehta

executive United States

Ketan Mehta is the chief executive of Tris Pharma, a company involved in developing new pain management therapies. He has overseen the development of cebranopadol, a novel painkiller that activates specific opioid receptors with a lower risk of addiction compared to traditional opioids.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Australia Australia: Ketan Mehta was one of the bankers advising Cox. 6

Donald Trump Joe Biden Eric Zinterhofer Winfrey Dallas Clement Dan Richards Christina Mohr Eduardo Mestre Dan Mendelow Derek Van Zandt Jeff Hogan Nancy Peretsman Byron Trott Aryeh Bourkoff Ehren Stenzler Taylor
The Sydney Morning Herald: The deal that started with a love letter

United Kingdom United Kingdom: Ketan Mehta is the chief executive of Tris Pharma. 7

Gregory Scherrer Anthony Dickenson Jeffrey Mogil Amanda Williams Mark Hutchinson Christopher Eccleston David Altshuler David Andersson
The Guardian: Painkillers without the addiction? The new wave of non-opioid pain relief | Science